USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck’s …